$MDB

Cochran Hope F sold $376K of MDB

Cochran Hope F sold 1,000 shares of MongoDB, Inc. (MDB) at $375.92 ($0.38M total) on 2026-09-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cochran Hope F
Published Sep 21, 2026, 8:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MDB
Neutral
high confidence
Mentioned
$MDB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MDBNeutralLow
01

Why it matters

The disclosed sale is modest and pre‑arranged, offering limited actionable insight.

02

Market read

Minor insider sale with low trading relevance; unlikely to affect price.

03

What to watch

Potential upcoming corporate actions or compensation plans not disclosed.

Relevance 3/10Novelty 5/10Timing: post‑market filing on Sep 21, 2026

Background

SEC Form 4 filing discloses insider transactions; directors often use 10b5‑1 plans for scheduled sales.

Company-level read

Ticker impact

$MDBNeutralHigh confidence
Context

Director Cochran Hope F sold 1,000 shares of MongoDB for $375,920 via a 10b5-1 plan.

Expected impact

Minimal short-term price pressure; unlikely to move the stock materially.

Evidence & confidence

The transaction amount ($376K) is small relative to market cap; director sales are routine and often pre‑arranged.

Market effects

No broader sector impact; insider sale is company‑specific.

None

None

Counterpoint

The sale could be purely liquidity‑driven and not reflect outlook.

Key entities

  • MongoDB, Inc.

    Database software provider listed on NASDAQ.

  • Cochran Hope F

    Member of MongoDB's board who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MDBMed

Yorkville Ives initiates MongoDB stock coverage with outperform rating

Yorkville Ives initiated coverage on MongoDB (NASDAQ:MDB) with an Outperform rating and a $430 price target, suggesting 19% upside. The company's Atlas platform is seen as key for AI production. MongoDB reaffirmed guidance, raised revenue growth targets, and authorized $1B in share buybacks. Recent product releases and leadership changes were noted. Analysts remain bullish, with consensus rating of 1.63 (Buy).

$MDBMed

Out with the new, back in with the old - what MongoDB's executive upheaval means for its strategic AI infrastructure push

MongoDB's former CEO, Dev Ittycheria, returns as interim CEO after current CEO Chirantan Desai resigned to join Meta. Ittycheria emphasizes MongoDB's focus on AI infrastructure, citing customer growth and strategic advantages in real-time data, scalability, and security. The company aims to expand its AI-native customer base and adapt to evolving workload demands.

$NVDAMedAI 8/10

Nvidia’s $150 Billion Buyback, Accenture’s 17.85% Surge and Corteva’s 84.31% Plunge Drive a Volatile US Stock Week

Nvidia authorized a $150B share buyback, boosting its program to $235B. Shares hit a record $237.39. Accenture rose 17.85% on record bookings. MongoDB fell 17% after CEO exit. Lifecore surged 56.19% on $663.7M buyout. Carnival gained 12.53% on earnings beat. Corteva dropped 84.31% after spin-off. Broader market indices rose on Fed rate hike expectations easing.

$MDBMed

Will New AI Product Launches Change MongoDB (MDB) Narrative

MongoDB (MDB) launched MongoDB 9.0, Atlas Infinite, and Atlas Agent Engine, focusing on AI and performance. The company increased its share repurchase authorization to $2 billion. Analysts expect revenues to reach $4.6 billion and earnings to hit $295.3 million by 2029, with a 27% potential upside. Risks include competitive pressure and economic factors.